BR100 Increased By (1.14%)
BR30 Increased By (1.36%)
KSE100 Increased By (0.9%)
KSE30 Increased By (0.94%)
BECO 5.75 Increased By ▲ 0.16 (2.86%)
BML 63.48 Increased By ▲ 2.45 (4.01%)
BOP 33.60 Increased By ▲ 0.35 (1.05%)
CNERGY 8.25 Increased By ▲ 0.20 (2.48%)
DCL 11.45 Increased By ▲ 0.15 (1.33%)
FCCL 53.00 Increased By ▲ 0.07 (0.13%)
FCSC 5.57 Increased By ▲ 0.23 (4.31%)
FFL 17.81 Increased By ▲ 0.20 (1.14%)
FNEL 1.31 No Change ▼ 0.00 (0%)
HUMNL 11.15 Increased By ▲ 0.03 (0.27%)
KEL 7.99 Increased By ▲ 0.10 (1.27%)
KOSM 5.50 Increased By ▲ 0.17 (3.19%)
MLCF 86.39 Increased By ▲ 1.04 (1.22%)
NBP 184.70 Increased By ▲ 3.41 (1.88%)
PACE 12.16 Increased By ▲ 0.63 (5.46%)
PAEL 40.45 Increased By ▲ 1.04 (2.64%)
PIAHCLA 25.75 Increased By ▲ 0.12 (0.47%)
PIBTL 17.33 Increased By ▲ 0.18 (1.05%)
PPL 226.09 Increased By ▲ 1.27 (0.56%)
PRL 34.39 Increased By ▲ 0.21 (0.61%)
PTC 65.80 Increased By ▲ 0.72 (1.11%)
SEARL 90.50 Increased By ▲ 0.90 (1%)
SSGC 26.89 Increased By ▲ 0.58 (2.2%)
TELE 8.60 Increased By ▲ 0.22 (2.63%)
THCCL 70.30 Increased By ▲ 0.96 (1.38%)
TPLP 11.31 Increased By ▲ 1.03 (10.02%)
TREET 24.53 Increased By ▲ 0.33 (1.36%)
TRG 71.98 Increased By ▲ 2.44 (3.51%)
WAVES 11.48 Increased By ▲ 0.45 (4.08%)
WTL 1.28 Increased By ▲ 0.01 (0.79%)
اردو
Android App
Print Edition Dollar to PKR
Budget 2026-27 Iran-US war Petrol Prices Gold Rates Podcasts PSX Notices
Business & Finance

India's Glenmark Pharma announces discovery of new monoclonal antibody

MUMBAI: Indian drugmaker Glenmark Pharmaceuticals said on Monday it has discovered a new molecule that can be used to
Published February 4, 2013 Updated February 4, 2013 10:19am
Save
1 min
comment
By Asad Naeem
Add BRecorder as a trusted
source on Google
Google Preferred Source

glenmark pharmaceuticals 40MUMBAI: Indian drugmaker Glenmark Pharmaceuticals said on Monday it has discovered a new molecule that can be used to treat diseases such as rheumatoid arthritis and inflammatory bowel disease.

 

The new molecule, named GBR 830, is an anti-OX40 monoclonal antibody, Glenmark said in a statement, adding that OX40 is responsible for some autoimmune diseases.

 

The company said it has initiated studies for an investigational new drug (IND) application to be filed with the US Food and Drug Administration.

Copyright Reuters, 2013

Comments

Comments are closed for this article.

More Stories

Browse all stories